GeoVax’s current product development pipeline is shown below.
News of Interest
February 5, 2019 - Message to Shareholders from David Dodd, Chairman & CEO
Vote for GeoVax in the 2019 Vaccine Industry Excellence Awards (ViE)
- Nominated in three categories!
David Dodd Interview with Proactive Investors at the 11th Annual Biotech Showcase
HVTN 114 - Results Presented at HIVR4P
HIV/AIDS Vaccines: 2018
authored by Harriet L. Robinson, PhD
Great Video by Georgia Research Alliance about impressive work being done at Emory Vaccine Center.
HIV - Immunotherapy Program
HIV - Preventive Vaccine
Zika Virus Vaccine
Hemorrhagic Fever Vaccine
Hepatitis B Therapeutic Vaccine
Malaria Vaccine Program